One possible reason may be its antidiabetic action by modulating the insulin and insulin-like growth factor (IGF1) signaling pathways (Schriner et al., 2014) since insulin resistance was proven to play a fundamental key role for MetS complications (Khan et al., 1990). Here, INS is linked to metabolic syndrome.